Pregled bibliografske jedinice broj: 1201854
The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy: a review from the ESGMYC study group
The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy: a review from the ESGMYC study group // European Respiratory Review, 31 (2022), 163; 210218, 14 doi:10.1183/16000617.0218-2021 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1201854 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The role of antibodies in tuberculosis diagnosis,
prophylaxis and therapy: a review from the ESGMYC
study group
Autori
Melkie, Solomon Tibebu ; Arias, Lilibeth ; Farroni, Chiara ; Janković Makek, Mateja ; Goletti, Delia ; Vilaplana, Cristina
Izvornik
European Respiratory Review (0905-9180) 31
(2022), 163;
210218, 14
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
antibodies, tuberculosis
Sažetak
Tuberculosis (TB) is still responsible for the deaths of >1 million people yearly worldwide, and therefore its correct diagnosis is one of the key components of any TB eradication programme. However, current TB diagnostic tests have many limitations, and improved diagnostic accuracy is urgently needed. To improve the diagnostic performance of traditional serology, a combination of different Mycobacterium tuberculosis (MTB) antigens and different antibody isotypes has been suggested, with some showing promising performance for the diagnosis of active TB. Given the incomplete protection conferred by bacille Calmette– Guérin (BCG) vaccination against adult pulmonary TB, efforts to discover novel TB vaccines are ongoing. Efficacy studies from advanced TB vaccines designed to stimulate cell- mediated immunity failed to show protection, suggesting that they may not be sufficient and warranting the need for other types of immunity. The role of antibodies as tools for TB therapy, TB diagnosis and TB vaccine design is discussed. Finally, we propose that the inclusion of antibody-based TB vaccines in current clinical trials may be advisable to improve protection.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinika za plućne bolesti "Jordanovac",
Klinički bolnički centar Zagreb
Profili:
Mateja Janković Makek
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE